TABLE 2.
Comparison of variables among patients with favorable and unfavorable outcomes
| Variable | Data for outcome ofa: |
P value | |
|---|---|---|---|
| Favorable | Unfavorable | ||
| Age (mean ± SD) (yr) | 44.50 ± 16.80 | 55.97 ± 17.86 | <0.001 |
| Gender | 0.005 | ||
| Women | 121 (58.7) | 105 (45.3) | |
| Men | 85 (41.3) | 127 (54.7) | |
| Elapsed time between OS & AVT (days)b | <0.001 | ||
| ≤2 | 113 (55.7) | 82 (35.7) | |
| >2 and ≤7 | 78 (38.4) | 113 (49.1) | |
| >7 | 12 (5.9) | 35 (15.2) | |
| Glasgow Coma Scale score (mean ± SD) | 13.80 ± 2.15 | 12.57 ± 3.05 | <0.001 |
| New-onset convulsionc | 31 (15.1) | 60 (26.2) | 0.005 |
| Immunosuppressiond | 24 (11.7) | 35 (15.1) | 0.29 |
a
Values are no. (%) of patients, unless otherwise indicated.
b
Elapsed time between onset of symptoms (OS) and the start of antiviral treatment (AVT).
c
Defined as a convulsion observed before therapy.
d
Defined as long-term steroid use or other immunosuppressive state.